161 related articles for article (PubMed ID: 20104999)
1. FRAME and the validation process.
Balls M; Clothier R
Altern Lab Anim; 2009 Dec; 37(6):631-40. PubMed ID: 20104999
[TBL] [Abstract][Full Text] [Related]
2. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
[TBL] [Abstract][Full Text] [Related]
3. Validation of alternative methods for toxicity testing.
Bruner LH; Carr GJ; Curren RD; Chamberlain M
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
[TBL] [Abstract][Full Text] [Related]
4. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
[No Abstract] [Full Text] [Related]
5. The principles of validation and the ECVAM validation process.
Worth AP; Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
[TBL] [Abstract][Full Text] [Related]
6. Practical Aspects of Designing and Conducting Validation Studies Involving Multi-study Trials.
Coecke S; Bernasconi C; Bowe G; Bostroem AC; Burton J; Cole T; Fortaner S; Gouliarmou V; Gray A; Griesinger C; Louhimies S; Gyves EM; Joossens E; Prinz MJ; Milcamps A; Parissis N; Wilk-Zasadna I; Barroso J; Desprez B; Langezaal I; Liska R; Morath S; Reina V; Zorzoli C; Zuang V
Adv Exp Med Biol; 2016; 856():133-163. PubMed ID: 27671721
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.
Judson R; Kavlock R; Martin M; Reif D; Houck K; Knudsen T; Richard A; Tice RR; Whelan M; Xia M; Huang R; Austin C; Daston G; Hartung T; Fowle JR; Wooge W; Tong W; Dix D
ALTEX; 2013; 30(1):51-6. PubMed ID: 23338806
[TBL] [Abstract][Full Text] [Related]
8. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
9. CON4EI: CONsortium for in vitro Eye Irritation testing strategy.
Van Rompay AR; Verstraelen S; Blaauboer BJ
Toxicol In Vitro; 2018 Jun; 49():1. PubMed ID: 29685209
[No Abstract] [Full Text] [Related]
10. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
Chahoud I; Grote K
Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
[No Abstract] [Full Text] [Related]
11. Use and validation of HT/HC assays to support 21st century toxicity evaluations.
Patlewicz G; Simon T; Goyak K; Phillips RD; Rowlands JC; Seidel SD; Becker RA
Regul Toxicol Pharmacol; 2013 Mar; 65(2):259-68. PubMed ID: 23291301
[TBL] [Abstract][Full Text] [Related]
12. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
13. Development of alternative methods.
Goldberg AM
J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238
[TBL] [Abstract][Full Text] [Related]
14. Uncertainty of testing methods--what do we (want to) know?
Paparella M; Daneshian M; Hornek-Gausterer R; Kinzl M; Mauritz I; Mühlegger S
ALTEX; 2013; 30(2):131-44. PubMed ID: 23665803
[TBL] [Abstract][Full Text] [Related]
15. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
16. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
Spielmann H
Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
[TBL] [Abstract][Full Text] [Related]
17. The patchwork of toxicological research for pharmaceutical testing.
von Aulock S
ALTEX; 2010; 27(1):1. PubMed ID: 20397314
[No Abstract] [Full Text] [Related]
18. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
[No Abstract] [Full Text] [Related]
19. Food for thought ... on validation. A puzzle or a mystery: an approach founded on new science.
Wilcox N; Goldberg A
ALTEX; 2011; 28(1):3-8. PubMed ID: 21311846
[TBL] [Abstract][Full Text] [Related]
20. Call to curb lab tests on dogs.
Turner M
Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
